Navigation Links
Study affirms effectiveness of medication for juvenile rheumatoid arthritis
Date:5/8/2008

m of 2 weeks before enrollment, while maintaining a low-dose regimen of corticosteroids or NSAIDs was allowed. Patients received injections of etanercept based on the patients body weight with a maximum weekly dosage of 50 milligrams. As the trial was extended beyond 1 year, participants were permitted to add low-dose MTX if recommended by their physician. At every 3 months during the first year of the extension phase, and then every 4 to 6 months during the following years, participants were assessed for improvement in overall disease status using the American College of Rheumatology Pediatric (ACR Pedi) criteria, as well as evaluated for changes in joint inflammation, mobility, pain, ability to perform routine daily tasks and C-reactive protein level. Patients were also monitored for frequency of serious adverse events (SAEs) such as those that required hospitalization, resulted in prolonged incapacity or death. Also medically important infections (MIIs) defined as those that required treatment with intravenous antibiotics were monitored.

58 JRA patients, 84 percent of the participants in the randomized controlled trial, enrolled in the long-term extension trial and received weekly treatment for a total of 318 patient years of etanercept exposure. Most patients were female (67 percent) and white (74 percent), and all had taken MTX prior to the study. At baseline, the mean age of the patients was 10 years and the mean duration of disease was 5.9 years. 42 of these patients (72 percent) entered the fourth year of continuous etanercept treatment, and 26 patients (45 percent) entered the eighth year. Heres an overview of the results:

  • 16 of the original 69 study participants reported 39 serious adverse events, for an overall exposure-adjusted rate of 0.12 SAEs per patient year. This rate did not increase with long-term exposure to etanercept.

  • 8 patients reported
    '/>"/>

Contact: Sean Wagner
swagner@wiley.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study identifies molecular response of cartilage to injury
2. Skin flaps deliver cancer-fighting therapy, ASPS study reveals
3. Pilot Study to Assess Safety and Efficacy of Medidur(TM) FA in AMD Patients Treated With Lucentis(R)
4. MIT study suggests caution on new anti-obesity drug in kids
5. Preliminary Results from Phase 2 Genzyme Study Highlight Potential of Novel Oral Compound for Gaucher Disease
6. Study in mice suggests molecules in plants have beneficial effect on Alzheimers disease
7. Women and heart attack: Study finds failure to recognize symptoms, failure to treat appropriately
8. Weill Cornell receives funding to study creation of new elder abuse center
9. Pilot study reinforces use of portable anteroom HEPA filtration
10. Warning: New Skin Cancer Study Finds Outdoor Workers are Less Likely to Get Screened for Skin Cancer
11. Study shows physician judgement important in reducing RSV-related hospitalizations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 2014 Deep Research ... is a professional and in-depth research report ... provides basic Chitosan information, including Chitosan definition, ... well as industry overview. This research covers ... as well as global industry analysis covering ...
(Date:7/30/2014)... July 30, 2014 Frozen shoulder (Adhesive capsulitis) ... likely to develop this nasty condition which occurs most frequently ... can last up to two and half years if not ... shoulder, and with good reason: it can render your shoulder ... that is, if you aren't in too much pain to ...
(Date:7/30/2014)... July 30, 2014 The report "Peracetic ... by Application (Healthcare, Food, Water Treatment, Pulp & Paper, ... ROW) - Global Trends & Forecasts to 2018". Peracetic ... of 229.54 kilotons by 2019, signifying a robust growth ... , Browse 83 market data tables and 33 figures ...
(Date:7/30/2014)... For patients with asthma, just believing an odor is ... at least 24 hours, a new study indicates. ... you think you smell," study author Cristina Jaen, a ... in a Monell news release. "Asthmatics often ... that an odor is harmful, our bodies react as ...
(Date:7/30/2014)... Amy Norton HealthDay Reporter ... in a garden might help soothe the agitation that commonly ... at 17 past studies, British researchers found evidence that watering ... soothe some dementia patients, anxiety. The study authors cautioned ... tough subject to study -- and the evidence of a ...
Breaking Medicine News(10 mins):Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 2Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 3Health News:Chitosan Market & Sialic Acid Industry Research Analysis for World, China Regions Available at DeepResearchReports.com 4Health News:Good News for Diabetics Suffering from Frozen Shoulder 2Health News:Good News for Diabetics Suffering from Frozen Shoulder 3Health News:Good News for Diabetics Suffering from Frozen Shoulder 4Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 2Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 3Health News:Peracetic Acid Market Worth $664.24 Million by 2018 – New Report by MarketsandMarkets 4Health News:Even Thinking an Odor is Harmful May Spur Asthma Symptoms 2Health News:Gardens a Center of Calm for People With Dementia 2Health News:Gardens a Center of Calm for People With Dementia 3
... service to new or existing customers., BOTHELL, ... CSCX ) announced today that it has initiated ... external,defibrillators (AEDs) manufactured between August 2006 and March ... have a component whose performance,doesn,t match the factory ...
... 2008 The AMERIGROUP Foundation,today announced a contribution ... Intelligence (SCHI) to enhance the organization,s vocational,training program., ... specifically educates,multiply handicapped, underprivileged children with special needs ... and alleviate the suffering of the,most vulnerable members ...
... ) announced today that the expanded clinical evaluation of its ReValving ... aortic stenosis continues to enroll patients at an accelerating pace. More ... centers in 20 countries. , ... IRVINE, Calif. ...
... Pri-Med New York,conference at the Jacob K. Javits ... prepared by MTBC, the innovative healthcare IT,company based ... of medical,billing, claims submission, reimbursement, EMR software, and ... scored less than 50%. The average number,of correct ...
... VIEW, Calif., Oct. 13 Based on its ... Sullivan recognizes,Infor-Med, Inc. with the 2008 North American ... novel Praxis(R) Electronic Medical Records,(EMR) version 4, featuring ... EMR system employs a unique technology that does ...
... call center based in the Dallas/Ft. Worth Metroplex,was included ... companies,in the country for the second straight year. Beryl ... last five years., The Inc. 5000 list is ... the economy - America,s independent-minded entrepreneurs. Taken,as a whole, ...
Cached Medicine News:Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 2Health News:Cardiac Science Initiates Voluntary Field Corrective Action of Certain AEDs 3Health News:AMERIGROUP Foundation Supports the School for Children with Hidden Intelligence 2Health News: CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008 2Health News:MTBC Practice Management Quiz Sends Message to Doctors: There is Real Room for Improvement or a Need to Outsource 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 2Health News:Frost & Sullivan Awards Infor-Med for its Electronic Medical Record Technology 3Health News:The Beryl Companies Named to Inc. 5000 List for Second Consecutive Year 2
(Date:7/30/2014)... 2014 PuraMed BioScience ® , Inc., ... (OTC) medicinal and healthcare products, announced today that ... along with the name,s red and yellow logo. ... name MigraPure ®  going forward. The new ... natural migraine pain reliever will be reintroduced into ...
(Date:7/30/2014)... Research and Markets has announced the addition ... 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... at a lower CAGR in developed countries; however, it is expected ... China , India , and ... growth of the hematology analyzers and reagents market is driven by ...
(Date:7/30/2014)... , July 30, 2014  Today the US Surgeon ... and outdoor sun tanning or sun burns stating they can ... Surgeon, General Boris Lushniak , says that "skin cancer ... and that too much exposure to indoor and outdoor ultraviolet ... Dermatology and Aesthetic Medicine, in Boca Raton, Florida ...
Breaking Medicine Technology:PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 2PuraMed BioScience Rebrands its Natural Migraine Relief Medication, LipiGesic M 3Hematology Analyzers & Reagents Market - Forecasts to 2019 2Indoor and Outdoor Sun Tanning or Sun Burns Directly Linked to Deadly Melanoma Skin Cancer 2
... The UST-9121 is an ... sector transducer with a wide ... frequencies, this transducer is designed ... an intercostal window. The versatility ...
... transducer is a curved ... the higher frequencies. Featuring ... this transducer provides exceptional ... frequency abdominal kidney bladder ...
... to Enzo Clinical Labs, a full service ... the leading regional labs in the country, ... of a large laboratory with the convenience ... Enzo was one of the area's first ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
Medicine Products: